Significant Accounting Policies (Details) - USD ($)	6 Months Ended	12 Months Ended
	Jun. 30, 2021	Dec. 31, 2020
Significant Accounting Policies (Details) [Line Items]
Contract liabilities	$ 70,847	$ 89,425
Medicare shared savings revenue		767,744
Revenue to recover costs incurred percentage	100.00%
Product return allowance	$ 4,070	26,839
FDIC insurance amount	250,000
Insured excess	$ 2,310,474	18,227
Percentage of customers accounts receivable billings	48.20%
Accounts receivable net	$ 189,425	165,464
Net patient services accounts receivable	84,568	71,655
Allowance of doubtful accounts	$ 13,972	13,972
Accounts receivable bill amount		15,498
Concentration risk percentage	10.00%
BTG patient service revenue [Member]
Significant Accounting Policies (Details) [Line Items]
Contract liabilities	$ 43,752	35,779
Consulting revenue [Member]
Significant Accounting Policies (Details) [Line Items]
Contract liabilities	$ 25,000	$ 47,864
Convertible Notes Payable [Member]
Significant Accounting Policies (Details) [Line Items]
Anti-dilutive securities (in Shares)		10,298,333
Stock Options [Member]
Significant Accounting Policies (Details) [Line Items]
Anti-dilutive securities (in Shares)	3,013,750	3,111,750
Product revenue [Member]
Significant Accounting Policies (Details) [Line Items]
Contract liabilities	$ 2,095	$ 5,782
Minimum [Member]
Significant Accounting Policies (Details) [Line Items]
Estimated useful lives	5 years
Maximum [Member]
Significant Accounting Policies (Details) [Line Items]
Estimated useful lives	7 years
Warrant [Member]
Significant Accounting Policies (Details) [Line Items]
Anti-dilutive securities (in Shares)	58,079,122	51,352,986
Unissued [Member]
Significant Accounting Policies (Details) [Line Items]
Anti-dilutive securities (in Shares)	165,000	200,000
Common Stock Issuable [Member]
Significant Accounting Policies (Details) [Line Items]
Anti-dilutive securities (in Shares)	13,750,000	13,750,000